Skip to main content
Home
Online First
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Online First
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
FDA Oncology Update
FDA Oncology Update
Mixed Findings in Annual Cancer Statistics Report
Read More
Gastrointestinal Cancers
,
FDA Oncology Update
FDA Grants Approval to Avapritinib for Patients with GIST
Read More
FDA Oncology Update
Recap of FDA Drug Approvals in 2019
Read More
Drug Profiles/Updates
,
FDA Oncology Update
December 19, 2019 - FDA News & Updates
Read More
Sarcoma
,
FDA Oncology Update
Regenerative Medicine Advanced Therapy Designation Granted to ADP-A2M4 for Synovial Sarcoma
Read More
Bladder Cancer
,
Immunotherapy
,
FDA Oncology Update
FDA Grants Priority Review to Keytruda for Patients with High-Risk, Non–Muscle-Invasive Bladder Cancer
Read More
FDA Oncology Update
Inrebic Receives FDA Approval for Adults with Myelofibrosis
Read More
FDA Oncology Update
FDA Approved Erleada for Metastatic Castration-Sensitive Prostate Cancer
Read More
FDA Oncology Update
Keytruda plus Lenvima Combo FDA Approved for Advanced Endometrial Carcinoma with No MSI-H or dMMR Tumors
Read More
FDA Oncology Update
FDA Approves Adakveo to Reduce Vaso-Occlusive Crises in Patients with Sickle-Cell Disease
Read More
1
2
3
4
5
6
7
Page 4 of 13
Results 31 - 40 of 121